Hemophagocytic syndrome in late-onset SLE patients

Japanese Journal of Clinical Immunology

Volumn 32, Issue 2, 2009, Pages 116-123

  Tabata, Rie ^a   Tabata, Chiharu ^b   Kita, Yoshio ^a   Namiuchi, Shunzo ^a   Terada, Makoto ^a   Nagai, Tomoko ^a  

^a Hyogo Prefectural Tsukaguchi Hospital   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Hemophagocytic syndrome; Late onset SLE

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; THROMBOCYTE ANTIBODY;

AGED; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DISEASE ASSOCIATION; DISEASE COURSE; DRUG PULSE THERAPY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEVER; HEMATOLOGIC DISEASE; HEMOPHAGOCYTIC SYNDROME; HUMAN; MACROPHAGE; MALAISE; MALE; ONSET AGE; PERICARDIAL EFFUSION; PHAGOCYTOSIS; PLEURA EFFUSION; PROGNOSIS; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

EID: 77953677901     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.32.116     Document Type: Article

References (25)

1. Henter JI, et al.: Histiocyte disorders. Crit Rev Oncol Hematol 50: 157-174, 2004.
2. Hochberg MC.: Up dating the American College of Rheumatology Revised Criteria for the classification of Systemic Lupus Erythematosus. Arthritis Rheum 40: 1725, 1997.
3. Risdall RJ, et al.: Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993-1002, 1979.
4. Stephan JL, et al.: Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11: 451-456, 1993.
5. Henter JI, et al.: Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78: 2918-2922, 1991.
6. Osugi Y, et al.: Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89: 4100-4103, 1997.
7. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 3: 69-75, 2004.
8. Mazodier K, et al.: Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106: 3483-3489, 2005.
9. Murohashi I, et al.: Serum levels of Th1/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome. Lab Hematol 12: 71-74, 2006.
10. Wong KF, et al.: The acute lupus hemophagocytic syndrome. Ann Intern Med 114: 387-390, 1991.
11. Kumakura S, et al.: Autoimmune-associated hemophagocytosis. Am J Hematol 50: 148-149, 1995.
12. Kumakura S, et al.: Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 14: 205-215, 2004.
13. Pu SJ, et al.: The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9: 96-100, 2000.
14. Padovan M, et al.: Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int 27: 735-741, 2007.
15. Koh ET, Boey ML.: Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21: 1463-1467, 1994.
16. Mak SK, et al.: Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 7: 23-28, 1998.
17. Beyan E, et al.: An uncommon cause of fever in the elderly: late-onset systemic lupus erythematosus. Clin Rheumatol 22: 481-283, 2003.
18. Wang J, et al.: Systemic lupus erythematosus a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 298: 485-491, 2007.
19. Qian J, Yang CD.: Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol 26: 807-810, 2007.
20. Pringe A, et al.: Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under recognized complication? Lupus 16: 587-592, 2007.
21. Tsuda H.: Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 65: 215-226, 1997.
22. Takasaki Y, et, al.: Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14: 367-375, 2004.
23. Chan MT, et al.: Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 35: 77-83, 2008.
24. Bombardier C, et al.: Derivation of the SLEDAL A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-640, 1992.
25. Kawa, K, et al.: Diagnosis and treatment of hemophagocytic syndrome. (Article in Japanese) Rinsho Ketsueki 46: 418-423, 2005.